Group 1 - The company HeMai Co., Ltd. announced its first share buyback on November 27, 2025, repurchasing 50,000 shares, which represents 0.04% of its total share capital of approximately 124 million shares, with a total transaction amount of about 4.92 million yuan [1] - The highest buyback price was 98.92 yuan per share, while the lowest was 97.88 yuan per share [1] - For the year 2024, the company's revenue composition indicates that 99.3% comes from the photovoltaic industry, with other businesses contributing 0.7% [1] Group 2 - As of the report date, the market capitalization of HeMai Co., Ltd. is 12.2 billion yuan [2]

Core Viewpoint - HeMai Co., Ltd. (688032.SH) announced its first share repurchase on November 27, 2025, through the Shanghai Stock Exchange, indicating a strategic move to enhance shareholder value [1] Summary by Categories Share Repurchase Details - The company repurchased 50,000 shares, which represents 0.04% of its total share capital [1] - The highest price for the repurchase was 98.92 yuan per share, while the lowest price was 97.88 yuan per share [1] - The total amount spent on the repurchase was 4.9248 million yuan, excluding transaction fees such as stamp duty and commission [1]

Core Viewpoint - HeMai Co., Ltd. (688032.SH), the highest-priced IPO in A-share history, is facing a significant share reduction by major shareholders, who plan to sell up to 3% of the company's shares in the next three months [1][4]. Group 1: Shareholder Actions - Major shareholders, including Hangzhou Gangzhi Investment Partnership and Han Hualong, hold a combined 8.94% of HeMai's shares and plan to reduce their holdings by up to 372,220 shares [4][5]. - If the maximum reduction occurs at the closing price of 100.89 CNY per share on November 25, the shareholders could realize approximately 376 million CNY [2][6]. Group 2: Stock Performance - HeMai's stock price has significantly declined from its peak of 1,338.88 CNY per share to around 100.89 CNY, marking an 80% drop [2][7]. - The company was initially celebrated for its high IPO price of 557.80 CNY per share, but it has since lost its status as a high-value stock [7]. Group 3: Financial Performance - HeMai's profitability has deteriorated, with a reported net profit of 344 million CNY in 2024, down 32.75% year-on-year, and a net loss of 59.11 million CNY in the first three quarters of 2025 [3][9]. - Despite a revenue increase of 31.86% in 2023, the company experienced a decline in net profit, indicating a trend of rising costs outpacing revenue growth [8][9]. Group 4: Market Position and Challenges - HeMai specializes in micro-inverter technology and was the top domestic supplier and second globally in product shipments [3]. - The company faces increasing competition in the photovoltaic storage market, which may impact its ability to return to high growth and recover its stock price [9].

Group 1 - Aolide plans to raise no more than 300 million yuan through a simplified procedure for issuing shares to specific targets, with net proceeds allocated to the production base project for OLED display core materials and to supplement working capital [1] - Wanbang's subsidiary has obtained a 10-year exclusive agency for sildenafil oral suspension, which is suitable for patients with swallowing difficulties [2] - Titan Technology and its affiliate plan to jointly invest in increasing capital for its subsidiary, Micro Detection, raising its registered capital from 10 million yuan to 50 million yuan [3] Group 2 - Jindike will not issue new batches of quadrivalent influenza virus split vaccine this year, having produced approximately 1.56 million doses [4] - Aladdin intends to purchase 35% equity of Youke for 61.25 million yuan, funded by its own or raised capital [5] - Gujia Home's application for a private placement of A-shares has been approved by the Shanghai Stock Exchange [7] Group 3 - Honghe Technology's application for a private placement of A-shares has been approved by the China Securities Regulatory Commission [9] - Guangdian Yuntong has won contracts totaling 308 million yuan for the construction of an artificial intelligence application pilot base [10] - Shanghai Mechanical plans to repurchase B-shares worth no more than 278 million yuan [11] Group 4 - Weiling Co. is planning a change of control, with shares representing 7.76% of the total being transferred [14] - Jiugang Hongxing intends to invest 200 million yuan to establish a wholly-owned subsidiary focusing on high-quality special steel materials [16] - Zhongjian Technology has submitted an application for H-share listing [17] Group 5 - Sainuo Medical has received registration approval for its coronary product in Pakistan [18] - Huafeng Aluminum plans to acquire 100% equity of Huafeng Puen for 100 million yuan [20] - Fuda Co. intends to establish a wholly-owned subsidiary with an investment of 30 million yuan [22] Group 6 - Su Yan Jingshen's application for a private placement of shares has been approved by the Shanghai Stock Exchange [24] - Zhongchuang Co. has set the inquiry transfer price at 25.75 yuan per share [25] - Jinpu Garden has had a lawsuit involving 26.557 million yuan accepted by the court [29] Group 7 - ICBC has approved the appointment of Zhao Guid as vice president [30] - Betta Pharmaceuticals has had its drug registration application for ensartinib accepted [32] - Times New Materials plans to invest 6 million euros to establish a wholly-owned subsidiary in Serbia [34] Group 8 - China State Construction has appointed Chen Yong as vice president [36] - Dayang Electric plans to invest 10 million yuan to establish an industrial fund [38] - Advanced Digital has appointed Liu Zhigang as deputy general manager [39] Group 9 - Tianqi Co. plans to transfer 7% equity of Youqi Intelligent for 130 million yuan [40] - Xinguo has submitted an application for H-share issuance and listing [42] - Jinhongshun's shareholder has terminated a share reduction plan [43] Group 10 - Wanrun Co.'s actual controller plans to increase shareholding between 365 million yuan and 730 million yuan [44] - Suzhou High-tech plans to sell 47% equity of its medical device subsidiary for 604 million yuan [45] - Huayou Cobalt's subsidiary has signed a product supply agreement with Yiwei Lithium Energy for approximately 127,800 tons of materials [47] Group 11 - China Communications has won 10 important projects totaling approximately 2.539 billion yuan [49] - Nopushin plans to raise no more than 1.45 billion yuan through a private placement [50] - Yun Aluminum plans to acquire minority stakes in three subsidiaries for a total of 2.267 billion yuan [51] Group 12 - Xiamen Tungsten plans to establish a 500 million yuan merger fund with multiple parties [52] - Aotewei has signed a contract worth approximately 700 million yuan [54] - Hemai Co.'s shareholders plan to reduce their holdings by no more than 3% [56]

Core Viewpoint - The company HeMai Co., Ltd. (688032.SH) announced a share reduction plan by its shareholder Gangzhi Investment and its concerted actor Han Hualong, intending to reduce up to 3% of the total share capital within a specified period due to funding needs [1][2]. Group 1: Share Reduction Plan - Gangzhi Investment and Han Hualong plan to reduce a total of up to 3,722,206 shares, representing no more than 3% of the company's total share capital, from December 17, 2025, to March 16, 2026 [1]. - The reduction will occur through centralized bidding and block trading, adhering to regulations that limit the amount sold in any 30-day period to 1% and 2% of the total shares, respectively [1]. Group 2: Shareholding Structure - As of the announcement date, Gangzhi Investment and Han Hualong collectively hold 11,090,120 shares, accounting for 8.94% of the total share capital of 124,073,545 shares [2]. - Gangzhi Investment holds 6,355,645 shares (5.12%), while Han Hualong holds 4,734,475 shares (3.82%) [2]. Group 3: IPO and Fundraising - HeMai Co., Ltd. went public on December 20, 2021, with an IPO price of 557.80 yuan per share, raising a total of 5.578 billion yuan, netting 5.406 billion yuan after expenses [3]. - The final net fundraising amount exceeded the original plan by 4.848 billion yuan, which was intended for various projects including the construction of a smart manufacturing base and the industrialization of energy storage inverters [3]. Group 4: Dividend Distribution - The company has announced several dividend plans, including a distribution of 30 yuan per 10 shares in May 2022, 53 yuan per 10 shares in June 2023, and 36 yuan per 10 shares in June 2024, along with stock bonuses [4].

Core Viewpoint - HeMai Co., Ltd. (688032.SH) experienced a significant decline in stock price, reaching a nearly five-month low due to planned share reductions by major shareholders [1] Group 1: Stock Performance - The stock price of HeMai Co., Ltd. dropped by 3.15% to 97.71 yuan, marking the lowest level since July 1 of this year [1] - The decline reflects market reactions to shareholder actions and potential concerns about future performance [1] Group 2: Shareholder Actions - Major shareholder Gangzhi Investment and its concerted party Han Hualong plan to reduce their holdings by up to 3% of the total share capital, equating to a maximum of 372.22 million shares [1] - The reduction is scheduled to occur between December 17, 2025, and March 16, 2026, through centralized bidding and block trading methods [1]

Core Viewpoint - Multiple companies are announcing share reductions by major shareholders, indicating potential shifts in ownership and investor sentiment in the market [1] Shareholder Reductions - Zhongfu Shenying: Eagle Group plans to reduce its stake by no more than 1% [1] - Luxiao Technology: Actual controller and concerted parties plan to reduce their stake by no more than 3% [1] - Chenxi Aviation: Controlling shareholder intends to reduce its stake by no more than 3% [1] - Zhongchen Co., Ltd.: Controlling shareholder plans to reduce its stake by no more than 3% [1] - HeMai Co.: Shareholders Gangzhi Investment and Han Hualong plan to collectively reduce their stake by no more than 3% [1] - Kaipu Testing: General Manager Li Yaping intends to reduce her stake by no more than 1% [1] - Bide Pharmaceutical: Chairman and General Manager Dai Lan plans to reduce his stake by no more than 148,800 shares [1] - Jinhongshun: Gaode Investment has completed the reduction of 4.1556 million shares [1] - Buke Co.: Controlling shareholder Shanghai Bujin has cumulatively reduced its stake by 0.94% [1] - Andeli: Controlling shareholder has reduced its stake by 0.54% [1] - Hongbai New Materials: Controlling shareholder Hongbai Chemical has reduced 7.1974 million shares [1] - Yongxin Zhicheng: Qian'an Venture Capital has cumulatively reduced its stake by 3.7% [1] Other Notable Events - Fusenmei: Vice General Manager and Board Secretary Zhang Fengshu has been placed under investigation and detention measures [1] - *ST Dongtong: Company stock is suspended and may face delisting [1]

人民财讯11月25日电，禾迈股份(688032)11月25日公告，合计持股8.94%的股东九智汇科(杭州)私募基金 管理有限公司—杭州港智投资合伙企业(有限合伙)(简称"港智投资")及其一致行动人韩华龙计划以集中 竞价和大宗交易的方式合计减持不超过372.22万股公司股票，合计减持比例不超过公司总股本的3%。 ...

证券代码：688032 证券简称：禾迈股份 公告编号：2025-058 杭州禾迈电力电子股份有限公司 关于持股 5%以上股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 大股东持股的基本情况 截至本公告披露日，九智汇科（杭州）私募基金管理有限公司－杭州港智投 资合伙企业（有限合伙）（曾用名：浙大九智（杭州）投资管理有限公司－杭州 港智投资合伙企业（有限合伙），以下简称"港智投资"）及其一致行动人韩华龙 先生合计持有杭州禾迈电力电子股份有限公司（以下简称"公司"）股份 11,090,120 股，占公司总股本 124,073,545 股的 8.94%。其中，港智投资持有 6,355,645 股，占公司总股本的 5.12%，韩华龙持有 4,734,475 股，占公司总股 本的 3.82%。 港智投资持有的股份为公司首次公开发行股票并在上海证券交易所科创板 上市（以下简称"IPO"）前取得的股份及公司实施资本公积转增股本相应增加的 股份，韩华龙持有的股份来源为通过大宗交易的方式受让港 ...

禾迈股份(688032.SH)发布公告，公司于近日收到股东港智投资及其一致行动人韩华龙出具的《减持股 份计划告知函》，因自身资金需求，港智投资及韩华龙计划在减持计划披露之日起15个交易日后的三个 月内，即2025年12月17日至2026年3月16日，以集中竞价和大宗交易的方式合计减持不超过372.22万股 公司股票，合计减持比例不超过公司总股本的3%。 ...